13F 机构持仓

5AM Venture Management, LLC

SAN FRANCISCO CA · SEC CIK 0001799883

2026Q22026Q1 更早 9 个季度 🔒
$3.60亿2026Q1 申报市值
20持仓数
79.8%前十大占比 · 第一大 15.7%
1 / 2新建仓 / 清仓
申报市值走势$2.88亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

ERAS 15.7%
TRDA 14.2%
TYRA 10.9%
CAMP 7.2%
CENTESSA PHARM 6.4%
PHVS 6.3%
MPLT 5.4%
TECX 5.2%
CLDX 4.4%
ARTV 4.2%

2026Q1 买入最多 按季末市值估算

ALXO 新建仓+$612.99万

2026Q1 卖出最多 按季末市值估算

ERAS 减仓-$3,105.64万
RLYB 减仓-$2,995.03万
VRDN 清仓-$2,292.28万
ELVN 清仓-$1,189.61万

2026Q1 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
VRDN VIRIDIAN THERAPEUTICS INC $00.00%0 -736,595-100.0% -$2,292.28万 清仓
ELVN ENLIVEN THERAPEUTICS INC $00.00%0 -772,477-100.0% -$1,189.61万 清仓
SLN SILENCE THERAPEUTICS PLC $250.96万0.70%476,200 00.0% — 不变
RLYB RALLYBIO CORP $261.73万0.73%291,788 -3,338,936-92.0% -$2,995.03万 减仓
— SKYE BIOSCIENCE INC $595.04万1.65%9,681,763 00.0% — 不变
ALXO ALX ONCOLOGY HLDGS INC $612.99万1.70%3,057,325 3,057,325— $612.99万 新建仓
BHVN BIOHAVEN LTD $625.17万1.74%738,972 00.0% — 不变
TARA PROTARA THERAPEUTICS INC $713.66万1.98%1,369,782 00.0% — 不变
GHRS GH RESEARCH PLC $805.17万2.24%572,665 00.0% — 不变
ZNTL ZENTALIS PHARMACEUTICALS INC $923.81万2.56%3,947,913 00.0% — 不变
SRZN SURROZEN INC $1,128.79万3.13%387,500 00.0% — 不变
EYPT EYEPOINT INC $1,353.45万3.76%1,050,000 00.0% — 不变
ARTV ARTIVA BIOTHERAPEUTICS INC $1,515.53万4.21%2,353,304 00.0% — 不变
CLDX CELLDEX THERAPEUTICS INC NEW $1,577.34万4.38%497,270 00.0% — 不变
TECX TECTONIC THERAPEUTIC INC $1,875.19万5.21%606,660 00.0% — 不变
MPLT MAPLIGHT THERAPEUTICS INC $1,931.37万5.36%950,011 00.0% — 不变
PHVS PHARVARIS N V $2,253.22万6.26%797,600 00.0% — 不变
— CENTESSA PHARMACEUTICALS PLC $2,307.51万6.41%580,945 00.0% — 不变
CAMP CAMP4 THERAPEUTICS CORP $2,588.27万7.19%5,869,091 00.0% — 不变
TYRA TYRA BIOSCIENCES INC $3,942.21万10.94%1,029,298 00.0% — 不变
TRDA ENTRADA THERAPEUTICS INC $5,119.15万14.21%4,056,379 00.0% — 不变
ERAS ERASCA INC $5,640.30万15.66%3,485,971 -1,919,433-35.5% -$3,105.64万 减仓